Digital Biomarkers Market
According to Intent Market Research, the Digital Biomarkers Market is expected to grow from USD 3.2 billion in 2023 at a CAGR of 22.6% to touch USD 13.2 billion by 2030. The Digital Biomarkers Market is dominated by key players such as Apple Inc., Fitbit (Google LLC), Garmin Ltd., Philips Healthcare, Omron Corporation, Samsung Electronics, Biogen Inc., Novartis International AG, Abbott Laboratories, Medtronic PLC, Xiaomi Corporation, Qualcomm Inc., Pear Therapeutics, Sensyne Health, Withings